CBD-containing products have become an increasingly valuable category for pharmacy retailers, but there is concern that some products on the market fail to meet standards expected in the sector. In a recent broadcast interview, Jasmine Shah from the National Pharmacy Association (NPA) said it was getting difficult for “a growing number of pharmacists” selling CBD products because current guidance was “difficult to interpret”.
The NPA elaborated on its position in a statement, saying: “In the case of CBD products, pharmacists should take account of current Home Office guidance, although it must be said the current guidance is difficult to interpret. Our advice to pharmacists considering whether to stock CBD products is to ensure they are acting legally and in the best interests of patients – which is the same advice we’d give about all other products sold or supplied in pharmacies.”
